Treatment of cancer by inhibiting activity or expression of late SV-40 factor

• 收藏
• 分享

专利权人:

Devanand Sarkar

发明人:

Devanand Sarkar,Paul B. Fisher

申请号：

US13636815

公开号：

US09283244B2

申请日:

2011.03.29

申请国别(地区):

US

年份:

2016

代理人:

摘要：

Inhibitors of Late SV-40 Factor (LSF) are used to treat cancers such as hepatocellular carcinoma (HCC). In particular, small molecule chemical LSF inhibitors are employed. In addition, the activity and/or pattern of expression of LSF may is used to diagnose cancer, to characterize the cancer (e.g. stage, grade, prognosis, etc.) and also to develop suitable protocols for cancer treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/